ResearchHub

2.3K posts

ResearchHub banner
ResearchHub

ResearchHub

@ResearchHub

A modern day preprint server powered by $RSC. Incentivizing the open publication of transparent research. Let's accelerate science!

Earth 🌍🌎🌏 Katılım Ocak 2019
1 Takip Edilen43.3K Takipçiler
Sabitlenmiş Tweet
ResearchHub
ResearchHub@ResearchHub·
Since January 2025, ResearchHub has deployed over $1.5M in research funding to scientists worldwide. We just redesigned our funding page to make it even easier for funders and researchers to connect. Take a look ↓ researchhub.com/fund
English
1
13
73
7.7K
ResearchHub retweetledi
Jeffrey Koury
Jeffrey Koury@jeffyfish9·
Was a pleasure moderating this powerhouse team at @NorthwellHealth /Feinstein Institute. Big takeaway from the session was how under rated Northwell is given their facilities for efficiently maneuvering through discovery, development, and deployment of therapies.
ResearchHub Foundation@ResearchHubF

Next, a superb panel on accelerating the pipeline from bench to bedside. @KevinJTraceyMD emphasized the importance of designing research from the outset with clinical translation in mind. @CliffordF66814 shared the advantage of @NorthwellHealth’s integrated system: in a recent case, they went from FDA approval to first clinical implementation in just 22 days. But it’s not just infrastructure and planning; it also takes courage. As @itchdoctor put it: “When your research is in clinical trials, you’re kind of sweating. Like, is my science going to hold up? But it’s about having the courage to put it out into the real world.”

English
0
5
13
1.7K
ResearchHub retweetledi
Brian S. Kim
Brian S. Kim@itchdoctor·
Innovation requires thinking about the patient first - science, engineering, trials, publishing, peer review, funding, etc. are all a means to the greatest end - alleviate human suffering.
ResearchHub Foundation@ResearchHubF

Next, a superb panel on accelerating the pipeline from bench to bedside. @KevinJTraceyMD emphasized the importance of designing research from the outset with clinical translation in mind. @CliffordF66814 shared the advantage of @NorthwellHealth’s integrated system: in a recent case, they went from FDA approval to first clinical implementation in just 22 days. But it’s not just infrastructure and planning; it also takes courage. As @itchdoctor put it: “When your research is in clinical trials, you’re kind of sweating. Like, is my science going to hold up? But it’s about having the courage to put it out into the real world.”

English
1
6
33
4.6K
ResearchHub retweetledi
ResearchHub Foundation
ResearchHub Foundation@ResearchHubF·
Today’s the day. Welcome to #CatalystNYC! We’re bringing together academics, funders, founders, and builders to reimagine how scientific discoveries get funded and turned into real-world impact. See you soon.
English
0
10
39
1.5K
ResearchHub retweetledi
ResearchHub Foundation
ResearchHub Foundation@ResearchHubF·
One day to go. Tomorrow, #CatalystNYC brings together leaders across science, biotech, philanthropy, venture, and government to discuss how research is funded, published, and translated into real-world impact. See you in New York.
English
0
5
25
844
ResearchHub retweetledi
ResearchHub retweetledi
ResearchHub Foundation
ResearchHub Foundation@ResearchHubF·
At #CatalystNYC, Cliff Friedman, Founder and Managing Partner of @NorthwellHealth Equity Partners, will join a panel on accelerating the path from scientific discovery to clinical application. Drawing on decades in healthcare investing and innovation, he’ll share what it takes to bridge that gap. Request an invitation → luma.com/66yycaak
ResearchHub Foundation tweet media
English
1
9
26
1.9K
ResearchHub
ResearchHub@ResearchHub·
Every scientific breakthrough started with a funder who believed in the project. However, the results don't always make it back out to the funder. We think backers of science deserve to know what happens next, and researchers deserve an outlet to share their findings. That's why we're working with scientists like Grigorii to create video updates, allowing funders and the broader community to follow scientific progress as it happens.
ResearchHub@ResearchHub

The blood-brain barrier blocks most drug therapies from reaching the brain, making it difficult to treat conditions like Alzheimer's and Parkinsons. What if we could bypass it? In 2024, Purdue PhD student Grigorii Rudakov submitted a proposal on ResearchHub: could DNA nanomaterials help therapeutics cross the BBB? His project was funded, and he got to work. Two years in, @grudakov2 has exciting results: his delivery system delivers across the BBB ~twice as well as the leading commercial agent. The results are early and done in a model system, but if it holds up, this work could change how we treat some of the most challenging diseases in medicine.

English
1
7
45
3.6K
ResearchHub retweetledi
Ruslan Rust
Ruslan Rust@rust_ruslan·
I just funded: Same Pathway as MOTS-c. Cheaper. Safer. The Brain-Body Imaging Data Just Doesn't Exist Yet on ResearchHub! researchhub.com/proposal/32204…
English
0
5
13
1.6K
ResearchHub retweetledi
ResearchHub Foundation
ResearchHub Foundation@ResearchHubF·
We’re excited to welcome Dr. Joni Rutter, Director of NCATS (National Center for Advancing Translational Sciences), as our Keynote Speaker at #CatalystNYC! As the head of @ncats_nih_gov, Dr. Rutter leads efforts to accelerate translational research, helping to turn laboratory results into real treatments. Rutter previously led the Division of Neuroscience and Behavior at @NIDAnews and ran scientific programs for the All of Us Research Program. Request your invite to Catalyst NYC here: luma.com/66yycaak
ResearchHub Foundation tweet media
English
1
10
34
1.6K
ResearchHub retweetledi
Ruslan Rust
Ruslan Rust@rust_ruslan·
How much does a scientific claim actually change between the preprint and the final published paper? We used a large language model to track it across all available 72,644 bioRxiv -> journal pairs from 2018 - 2025 in this new work with @HaoYin. 🧵
Ruslan Rust tweet media
English
9
62
200
78.3K
ResearchHub retweetledi
ResearchHub
ResearchHub@ResearchHub·
Q2 recap is live! $500k+ in research funding, an all-new funder dashboard, our first Stage 2 Registered Report, and more. Check out this article for the full list. In Q3, we're focusing heavily on funding. Our goal is to make backing science more seamless than ever. If you're a funder and want to see what tools are already live, check out our funder and donor guide: docs.researchhub.com/researchhub/pr…
ResearchHub Foundation@ResearchHubF

x.com/i/article/2069…

English
1
4
31
2K
ResearchHub
ResearchHub@ResearchHub·
A $150 peer review bounty is live on ResearchHub for this viral preprint on the information theory of aging. Using a new technique called SeqTag, researchers measured gene expression, chromatin accessibility, and histone modifications in the same aging cells. Their findings suggest aging may involve the gradual loss of cellular information, not just the accumulation of damage. If you have an expert scientific opinion on this, why not earn $150 in $RSC to share it on ResearchHub? → researchhub.com/paper/11304230…
David Sinclair@davidasinclair

NEW PREPRINT: Scientists may have found direct evidence that aging is driven by the loss of cellular information, not just the accumulation of damage For decades we've focused on what aging cells accumulate. This paper focuses on what they lose: Information. Using a new technology called SeqTag, researchers measured gene expression, chromatin accessibility, and histone modifications in the same aging cells. What they found was striking: the regulatory systems that tell cells who they are become increasingly out of sync with age. The authors call this "molecular asynchrony." As cells age, chromatin structure, histone marks, and gene expression begin drifting apart. Regulatory entropy rises. Repressive chromatin erodes. Cells become less certain of their identity and more likely to drift toward alternative fates. This is what the Information Theory of Aging (ITOA) states: that aging occurs when cells lose epigenetic information, the instructions that tell the genome how to maintain youthful function. DNA may remain largely unchanged, but the system that reads it gradually loses fidelity. What's remarkable is that this paper doesn't just describe this phenomenon. It quantifies it. The authors measure increasing regulatory entropy, loss of H3K27me3-mediated repression, erosion of heterochromatin, weakening lineage fidelity, and increased cell-fate drift during aging. In progenitor cells, the barriers that normally preserve cellular identity become progressively weaker with age. Mechanistically, the study argues that aging is associated with increasing molecular asynchrony between chromatin accessibility, H3K27ac/H3K27me3 remodeling, and transcriptional state. This decoupling is accompanied by increased regulatory entropy, loss of repressive chromatin architecture, and weakening of lineage constraints. Genes affected are those involved in chromatin organization, DNA damage, and Wnt signaling, consistent with ITOA. Importantly, the authors provide quantitative evidence that age-related heterochromatin erosion lowers the energetic barriers that maintain cell identity, offering a potential mechanistic link between epigenetic information loss, cell-fate drift, and late-life disease susceptibility 👏

English
1
4
41
4.3K
ResearchHub
ResearchHub@ResearchHub·
The blood-brain barrier blocks most drug therapies from reaching the brain, making it difficult to treat conditions like Alzheimer's and Parkinsons. What if we could bypass it? In 2024, Purdue PhD student Grigorii Rudakov submitted a proposal on ResearchHub: could DNA nanomaterials help therapeutics cross the BBB? His project was funded, and he got to work. Two years in, @grudakov2 has exciting results: his delivery system delivers across the BBB ~twice as well as the leading commercial agent. The results are early and done in a model system, but if it holds up, this work could change how we treat some of the most challenging diseases in medicine.
English
3
15
69
7.8K